GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, has announced that it has raised US$45 million in a Series C financing led by Gilde Healthcare Partners with participation from existing institutional investors MVM Partners, MedTech Venture Partners, and BlueStone Venture Partners.
Latham & Watkins LLP represented GT Medical Technologies in the financing with a corporate team led by Bay Area partner Luke Bergstrom, with associates Omar Ammash, Erica Kucharski, Autumn Schmidt, and Jude Baldo. Advice was also provided on tax and benefits & compensation matters by Bay Area partner Ashley Wagner.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
